AVVAA World Health Care Products, Inc. (AVVH)
- Previous Close
0.0016 - Open
0.0015 - Bid --
- Ask --
- Day's Range
0.0015 - 0.0016 - 52 Week Range
0.0008 - 0.0036 - Volume
279,000 - Avg. Volume
511,299 - Market Cap (intraday)
23,680 - Beta (5Y Monthly) -1.60
- PE Ratio (TTM)
-- - EPS (TTM)
-1.4900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.
avvaaworldhealth.comRelated News
Performance Overview: AVVH
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVVH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVVH
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.40
Enterprise Value/EBITDA
-0.02
Financial Highlights
Profitability and Income Statement
Profit Margin
45,873.67%
Return on Assets (ttm)
-1,593.67%
Return on Equity (ttm)
--
Revenue (ttm)
37.46k
Net Income Avi to Common (ttm)
17.18M
Diluted EPS (ttm)
-1.4900
Balance Sheet and Cash Flow
Total Cash (mrq)
3.17k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-22.46M
Company Insights: AVVH
AVVH does not have Company Insights